Recent Finacing
Recent Raise
Aramis Biosciences is a clinical-stage immuno‑ophthalmology biopharma developing A197, a first‑in‑class topical immunomodulator for dry eye, advancing toward Phase II, licensed and CMC/supply-partnered with Dompé using EXSCALATE AI.
